Singapore markets closed

Straits Times Index
3,323.20
-6.89(-0.21%)
S&P 500
5,306.04
+1.32(+0.02%)
Dow
38,852.86
-216.74(-0.55%)
Nasdaq
17,019.88
+99.08(+0.59%)
Bitcoin USD
67,847.42
-674.53(-0.98%)
CMC Crypto 200
1,462.66
-22.03(-1.48%)

PFE Mar 2025 17.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

11.70

0.00

(0.00%)

As of 12:10PM EDT. Market open.

Zacks
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
Zacks
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.